What is Amwell?
Amwell operates at the intersection of technology and clinical care, providing a comprehensive platform designed to facilitate seamless interactions across the health continuum. By connecting providers, payers, and innovators, the company fosters an ecosystem that integrates in-person, virtual, and automated care modalities. This holistic approach is engineered to improve patient outcomes while simultaneously driving operational efficiencies for healthcare organizations. As a leader in the telehealth space, Amwell's market position is defined by its scalability and its commitment to creating a unified, patient-centric experience that transcends geographical and systemic barriers.
How much funding has Amwell raised?
Amwell has raised a total of $1.4B across 6 funding rounds:
Series C
$81M
Other Financing Round
$5M
Other Financing Round
$290.6M
Multiple Rounds
$1B
Series C (2014): $81M, investors not publicly disclosed
Other Financing Round (2015): $5M led by Inventure
Other Financing Round (2018): $290.6M supported by Allianz X and Koninklijke Philips
Series C (2020): $194M featuring Takeda Pharmaceutical Company and Allianz X
Share Placement (2020): $100M backed by Google
Stock Issuance/Offering (2020): $742M, investors not publicly disclosed
Key Investors in Amwell
Allianz X
Allianz X is the strategic growth investments arm of Allianz Group, focused on investing in companies with exceptional growth potential in the financial services and insurtech sectors.
Koninklijke Philips
Philips is a global leader in health technology, combining clinical expertise and consumer insights to deliver integrated solutions across the health continuum.
GV is a venture capital firm that invests across multiple stages and sectors, focusing on enterprise solutions, life sciences, and frontier technology innovations.
What's next for Amwell?
Looking ahead, Amwell is well-positioned to leverage its recent capital influx to accelerate the deployment of its automated care solutions and expand its footprint in the enterprise health market. The strategic focus will likely center on enhancing interoperability between disparate health systems and refining the user experience for both clinicians and patients. By maintaining its focus on high-conviction partnerships and technological innovation, Amwell is poised to navigate the complexities of the evolving healthcare landscape, ensuring that its platform remains the preferred choice for organizations seeking to modernize their care delivery models and achieve long-term sustainability in a competitive digital health environment.
See full Amwell company page
